-
EP2240473
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2240473
| EP2240473 - SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.12.2015 Database last updated on 15.06.2024 | Most recent event Tooltip | 25.12.2015 | Application deemed to be withdrawn | published on 27.01.2016 [2016/04] | Applicant(s) | For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine, CA 92612 / US | [N/P] |
| Former [2010/48] | For all designated states Allergan, Inc. 2525 Dupont Drive Irvine, CA 92612 / US | ||
| Former [2010/42] | For all designated states Allergan, Inc. 2525 Dupont Drive Irvine, CA 92613 / US | Inventor(s) | 01 /
OLD, David, W. 13771 Typee Way Irvine CA 92620 / US | [2010/42] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastrasse 30 81925 München / DE | [N/P] |
| Former [2010/42] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | ||
| Former [2010/42] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 DE-81925 München / DE | Application number, filing date | 09706478.6 | 23.01.2009 | [2010/42] | WO2009US31855 | Priority number, date | US20080024295 | 29.01.2008 Original published format: US 24295 | US20090354919 | 16.01.2009 Original published format: US 354919 | [2010/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009097223 | Date: | 06.08.2009 | Language: | EN | [2009/32] | Type: | A1 Application with search report | No.: | EP2240473 | Date: | 20.10.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.08.2009 takes the place of the publication of the European patent application. | [2010/42] | Search report(s) | International search report - published on: | EP | 06.08.2009 | Classification | IPC: | C07D409/06, A61K31/4025, A61P27/06, A61Q7/00, A61K8/49 | [2010/42] | CPC: |
C07D409/06 (EP,US);
A61K8/4986 (EP,US);
A61P17/14 (EP);
A61P27/02 (EP);
A61P27/06 (EP);
A61Q7/00 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/42] | Title | German: | SUBSTITUIERTE GAMMALACTAME ALS THERAPEUTIKA | [2010/42] | English: | SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS | [2010/42] | French: | GAMMA LACTAMES SUBSTITUÉS EN TANT QU'AGENTS THÉRAPEUTIQUES | [2010/42] | Entry into regional phase | 05.08.2010 | National basic fee paid | 05.08.2010 | Designation fee(s) paid | 05.08.2010 | Examination fee paid | Examination procedure | 05.08.2010 | Examination requested [2010/42] | 18.10.2010 | Amendment by applicant (claims and/or description) | 19.04.2013 | Despatch of a communication from the examining division (Time limit: M04) | 29.05.2013 | Reply to a communication from the examining division | 01.08.2015 | Application deemed to be withdrawn, date of legal effect [2016/04] | 14.09.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2016/04] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 19.04.2013 | Fees paid | Renewal fee | 25.01.2011 | Renewal fee patent year 03 | 25.01.2012 | Renewal fee patent year 04 | 25.01.2013 | Renewal fee patent year 05 | 27.01.2014 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.01.2015 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2006098918 (ALLERGAN INC [US], et al) [X] 1-9 * page 72; example 16 * * page 73; examples 17,19 * * page 74; example 27 * * page 75; example 28 * * page 76; examples 36,39,40 * * page 41 * * page 44, lines 6-20,23-25,29,30 * * page 79, lines 27-29 * * claims 14,15 *; | [PX]WO2008094912 (ALLERGAN INC [US], et al) [PX] 1-9 * claims 1,14-17 ** page 25; compounds 7,8,9,3 * |